Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Maarten Albersen, Riccardo Campi et al.|European Urology Oncology|2020Cited by 50
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International ConsensusSimon K. B. Spohn, Constantinos Zamboglou, Ronald Chen et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 25
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Frontiers in Oncology|2023Cited by 8
Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry.Margaret Meagher, Ithaar Derweesh, Ricardo Autorino et al.|Journal of Clinical Oncology|2020Cited by 1
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCOREM Mir, Michele Marchioni, Riccardo Campi et al.|The Journal of Urology|2020Cited by 0